Old National Bancorp’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,894
Closed -$273K 619
2025
Q3
$273K Sell
1,894
-39
-2% -$5.32K ﹤0.01% 504
2025
Q2
$245K Buy
+1,933
New +$237K ﹤0.01% 519
2016
Q3
Sell
-4,104
Closed -$352K 629
2016
Q2
$352K Sell
4,104
-46,191
-92% -$4.14M 0.02% 433
2016
Q1
$4.37M Sell
50,295
-147,669
-75% -$13.2M 0.26% 95
2015
Q4
$22.3M Buy
197,964
+10,815
+6% +$1.17M 1.32% 16
2015
Q3
$18.9M Buy
187,149
+9,663
+5% +$1.16M 1.15% 23
2015
Q2
$21.8M Buy
177,486
+14,619
+9% +$1.75M 1.23% 18
2015
Q1
$18.6M Buy
+162,867
New +$18M 1.02% 29

Other funds holding IBB

Old National Bancorp's IBB Position: Q4 2025 in Review

Old National Bancorp sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 1,894 shares — an estimated $273K sold.

Old National Bancorp first reported a position in IBB in Q1 2015 and held it in 8 quarters. The position peaked at $22.3M in Q4 2015. 958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Old National Bancorp reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Old National Bancorp sold 1,894 iShares Biotechnology ETF shares in Q4 2025, an estimated $273K.
  • Old National Bancorp first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 8 quarters.
  • Old National Bancorp's iShares Biotechnology ETF position peaked at $22.3M in Q4 2015.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Old National Bancorp's 13F filing for Q4 2025, filed 28 Jan 2026.